Tango Therapeutics, Inc.
NASDAQ:TNGX
2.83 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -101.744 | -108.176 | -58.235 | -51.972 | -14.095 |
| Depreciation & Amortization
| 2.415 | 1.608 | 0.897 | 0.718 | 0.643 |
| Deferred Income Tax
| -0.295 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 19.079 | 14.23 | 7.833 | 1.764 | 1.694 |
| Change In Working Capital
| -37.966 | -18.493 | -11.345 | 118.674 | 1.696 |
| Accounts Receivables
| 2 | 0 | 0 | -2 | 0 |
| Inventory
| -6.734 | 0 | 0 | 0.422 | 0 |
| Accounts Payables
| -1.705 | 1.097 | 1.232 | 1.171 | 0 |
| Other Working Capital
| -31.527 | -19.59 | -12.577 | 119.081 | 1.696 |
| Other Non Cash Items
| 0.529 | 1.751 | 1.323 | 0.89 | -14.741 |
| Operating Cash Flow
| -117.982 | -109.08 | -59.527 | 70.074 | -24.803 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -1.526 | -7.692 | -1.837 | -1.106 | -1.817 |
| Acquisitions Net
| -42.952 | -34.091 | 181.597 | 0 | 0 |
| Purchases Of Investments
| -310.574 | -208.504 | -372.361 | -207.54 | 0 |
| Sales Maturities Of Investments
| 353.526 | 242.595 | 190.764 | 63.22 | 0 |
| Other Investing Activites
| 42.952 | 34.091 | -181.597 | -0.04 | 2.665 |
| Investing Cash Flow
| 41.426 | 26.399 | -183.434 | -145.466 | 0.848 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | -342.113 | -0.655 | 0 |
| Common Stock Issued
| 80.017 | 1.623 | 29.99 | 80.884 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 2.389 | -0.008 | 327.335 | 0.655 | 11 |
| Financing Cash Flow
| 82.406 | 1.615 | 357.325 | 80.884 | 11 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 38.123 |
| Net Change In Cash
| 5.85 | -81.066 | 114.364 | 5.492 | 25.168 |
| Cash At End Of Period
| 69.808 | 63.958 | 145.024 | 30.66 | 25.168 |